Lagevrio is a powerful drug for COVID-19.
- Lagevrio (also known as molnupiravir) has shown to decrease the rate of hospitalization or death for COVID-19 patients by approximately 50%.
- Lagevrio is not yet available in the United States, but when it is available, it will likely require a prescription.
- Patients will likely be able to present a positive COVID-19 test to receive a prescription directly at their local pharmacies.